Clinical Trial Update: A Pivotal Study to Evaluate Guardian™ Connect CGM System Performance in China [NA]

View source ↗

Summary

Pivotal study evaluating Guardian Connect CGM system performance in China has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Guardian Connect CGM System

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2020-08-21